PSMA-617 for Metastatic Castration-Resistant Prostate Cancer. The New England Journal of Medicine, 385(12), 1091–1103.

There is still much work to be done to help people with cancer live longer and better lives and I am excited to reimagine medicine together with my colleagues at Novartis." ...

Charlotte Maxeke Johannesburg Academic Hospitals breast health clinic will alleviate congestion in outpatient departments and improve patient experience. The oncology ward at Charlotte Maxeke ...

Novartis chief executive Vas Narasimhan said the partnership “will help us deliver on our purpose to reimagine medicine to improve and extend lives,” while his counterpart at Microsoft ...

Novartis is a focused innovative medicines company. Every day, we work to reimagine medicine to improve and extend people's lives so that patients, healthcare professionals and societies are ...

MONTREAL, Feb. 3, 2025 /CNW/ - Novartis Pharmaceuticals Canada Inc. (Novartis) is pleased to announce that, effective February 1, 2025, Nova Scotia is publicly funding Pluvicto™ (lutetium (177Lu ...

Novartis AG (NVS) has disclosed a new risk, in the Corporate Activity and Growth category. Novartis AG faces significant risks in its strategy of ...

MONTREAL, Feb. 3, 2025 /CNW/ - Novartis Pharmaceuticals Canada Inc. (Novartis) is pleased to announce that, effective February 1, 2025, Nova Scotia is publicly funding Pluvicto™ (lutetium (177Lu) ...

Saint Louis University's School of Medicine has a long tradition of excellence in medical school, graduate medical education and graduate education. Established in 1836, the school has the distinction ...